GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Gross Margin %

Bavarian Nordic A/S (Bavarian Nordic A/S) Gross Margin % : 65.97% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Bavarian Nordic A/S Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Bavarian Nordic A/S's Gross Profit for the three months ended in Dec. 2023 was $236 Mil. Bavarian Nordic A/S's Revenue for the three months ended in Dec. 2023 was $358 Mil. Therefore, Bavarian Nordic A/S's Gross Margin % for the quarter that ended in Dec. 2023 was 65.97%.


The historical rank and industry rank for Bavarian Nordic A/S's Gross Margin % or its related term are showing as below:

BVNRY' s Gross Margin % Range Over the Past 10 Years
Min: 30.05   Med: 56.65   Max: 78.79
Current: 65.18


During the past 13 years, the highest Gross Margin % of Bavarian Nordic A/S was 78.79%. The lowest was 30.05%. And the median was 56.65%.

BVNRY's Gross Margin % is ranked better than
55.92% of 735 companies
in the Biotechnology industry
Industry Median: 59.4 vs BVNRY: 65.18

Bavarian Nordic A/S had a gross margin of 65.97% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Bavarian Nordic A/S was 5.00% per year.


Bavarian Nordic A/S Gross Margin % Historical Data

The historical data trend for Bavarian Nordic A/S's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Gross Margin % Chart

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.45 35.48 30.05 53.99 65.18

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.48 65.78 65.58 62.63 65.97

Competitive Comparison of Bavarian Nordic A/S's Gross Margin %

For the Biotechnology subindustry, Bavarian Nordic A/S's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's Gross Margin % falls into.



Bavarian Nordic A/S Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Bavarian Nordic A/S's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=673.5 / 1033.291
=(Revenue - Cost of Goods Sold) / Revenue
=(1033.291 - 359.819) / 1033.291
=65.18 %

Bavarian Nordic A/S's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=236.2 / 358.059
=(Revenue - Cost of Goods Sold) / Revenue
=(358.059 - 121.847) / 358.059
=65.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Bavarian Nordic A/S  (OTCPK:BVNRY) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Bavarian Nordic A/S had a gross margin of 65.97% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Bavarian Nordic A/S Gross Margin % Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (Bavarian Nordic A/S) Headlines

From GuruFocus

Q2 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Bavarian Nordic A/S - Special Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2020 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Bavarian Nordic A/S Conference Call Transcript

By GuruFocus Research 02-13-2024